Study of Ki67 proliferation index association with clinico-pathological features of non-Hodgkin’s lymphoma at Tishreen University Hospital

Authors

  • Azza Ibraheem tishreen university
  • Firas Hussein Tishreen University
  • Samer Akel Tishreen University

Abstract

Purpose : we aim to study the Correlation between the Proliferative index Ki67 and clinical variables (staging ,B symptoms ), demographic variables (age , sex) , histologic variables (subtype of NHL , anatomic site , extra nodal involvement , bone marrow involvement ) in NHL patients .

Method: the study sample consisted of 90 patients who were admitted and treated at the Cancer Treatment Center in Tishreen University Hospital between 2015 and 2020 , we did a retrospective study on the files of NHL lymphoma patients who achieved the inclusion criteria and studied the previous variables and Ki67

Results: the value of Ki67 was between 3% and 100% with a median value approximates   50,2%±26,2% . we divided patients into two groups depending on the value of Ki67 : ≥45% and <45% , the we compared the previous variables with this two groups . the difference of age and sex between the two Ki67 value groups were not statically (P-value :0,311/0,449  in respect ) or clinically significant , so as the staging according to the Ann Arbor staging system ( P-value:0,207) . we noticed that  there was a  significant association to the subtypes of NHL , the value of Ki67≥45% was associated with DLBCL ، Burkit ، High Grade B Cell . whereas the value of Ki67<45% were associated basically  with FL ، SLL ، Small B Cell ، T Cell Rich B Cell with astatically importance ( p-value : 0,006) . lastly the value of Ki67≥45% was associated with high levels of extra nodal sites (P-value: 0,001)  , B symptoms (P-value : 0,020 )   , bone marrow involvement  (P-value: 0,001)   and high levels of LDH (P-value:0,001) .

Conclusion : our study showed that there was significant association between high values of Ki67 (≥45%) and the more aggressive subtypes of NHL and also with positive  extra nodal sites ,B symptoms and bone marrow involvement .

Downloads

Published

2022-09-07

How to Cite

1.
ابراهيم ع, فراس حسين, سامر عاقل. Study of Ki67 proliferation index association with clinico-pathological features of non-Hodgkin’s lymphoma at Tishreen University Hospital. Tuj-hlth [Internet]. 2022Sep.7 [cited 2024Apr.26];44(4):223-44. Available from: https://journal.tishreen.edu.sy/index.php/hlthscnc/article/view/12738

Issue

Vol. 44 No. 4 (2022): Tishreen University Journal for Research and Scientific Studies - Health Sciences Series

Section

Master student researches

License

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.

The authors retain the copyright and grant the right to publish in the magazine for the first time with the transfer of the commercial right to Tishreen University Journal for Research and Scientific Studies - Health Sciences Series

 Under a CC BY- NC-SA 04 license that allows others to share the work with of the work's authorship and initial publication in this journal. Authors can use a copy of their articles in their scientific activity, and on their scientific websites, provided that the place of publication is indicted in  Tishreen University Journal for Research and Scientific Studies - Health Sciences Series   .  The Readers have the right to send, print and subscribe to the initial version of the article, and the title of  Tishreen University Journal for Research and Scientific Studies - Health Sciences Series  Publisher

journal uses a CC BY-NC-SA license which mean

You are free to:

  • Adapt — remix, transform, and build upon the material
  •  
  • The licensor cannot revoke these freedoms as long as you follow the license terms.

 

  • Attribution — You must give appropriate credit, provide a link to the license, and indicate if changes were made. You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.
  • NonCommercial — You may not use the material for commercial purposes.
  • ShareAlike — If you remix, transform, or build upon the material, you must distribute your contributions under the same license as the original.
  • No additional restrictions — You may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.

Most read articles by the same author(s)